PROCEPT BioRobotics Corporation (PRCT)

NASDAQ: PRCT · IEX Real-Time Price · USD
49.06
+0.72 (1.49%)
Mar 1, 2024, 4:00 PM EST - Market closed
1.49%
Market Cap 2.48B
Revenue (ttm) 136.19M
Net Income (ttm) -105.90M
Shares Out 50.77M
EPS (ttm) -2.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 629,569
Open 48.91
Previous Close 48.34
Day's Range 48.00 - 49.57
52-Week Range 24.83 - 52.32
Beta 1.03
Analysts Strong Buy
Price Target 45.83 (-6.58%)
Earnings Date Feb 27, 2024

About PRCT

PROCEPT BioRobotics Corporation, a surgical robotics company, focused on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is he... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Sep 15, 2021
Employees 626
Stock Exchange NASDAQ
Ticker Symbol PRCT
Full Company Profile

Financial Performance

In 2023, PRCT's revenue was $136.19 million, an increase of 81.55% compared to the previous year's $75.01 million. Losses were -$105.90 million, 21.5% more than in 2022.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for PRCT stock is "Strong Buy." The 12-month stock price forecast is $45.83, which is a decrease of -6.58% from the latest price.

Price Target
$45.83
(-6.58% downside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

SAN JOSE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transfo...

5 days ago - GlobeNewsWire

PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston

SAN JOSE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solu...

20 days ago - GlobeNewsWire

PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million

SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transfor...

7 weeks ago - GlobeNewsWire

PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City

SAN JOSE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solu...

3 months ago - GlobeNewsWire

PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transfor...

4 months ago - GlobeNewsWire

PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023

SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transfo...

4 months ago - GlobeNewsWire

PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan

REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in surgical robotics, announced today that it has succe...

6 months ago - GlobeNewsWire

PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston

REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative ...

7 months ago - GlobeNewsWire

PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock

REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by develo...

7 months ago - GlobeNewsWire

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by develo...

7 months ago - GlobeNewsWire

PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tran...

7 months ago - GlobeNewsWire

PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023

REDWOOD CITY, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing tra...

8 months ago - GlobeNewsWire

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotic...

8 months ago - Accesswire

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACECSSWIRE / May 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotic...

10 months ago - Accesswire

INVESTIGATION ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotic...

10 months ago - Accesswire

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotic...

10 months ago - Accesswire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $PRCT #PRCT--The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors to Contact the Firm.

11 months ago - Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $PRCT #PRCT--The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors to Contact the Firm.

11 months ago - Business Wire

PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

REDWOOD CITY, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tr...

11 months ago - GlobeNewsWire

PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas

REDWOOD CITY, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing tr...

11 months ago - GlobeNewsWire

PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago

REDWOOD CITY, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tr...

1 year ago - GlobeNewsWire

PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum

REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tr...

1 year ago - GlobeNewsWire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results

REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tra...

1 year ago - GlobeNewsWire

PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston

REDWOOD CITY, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tra...

1 year ago - GlobeNewsWire

PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solu...

1 year ago - GlobeNewsWire